Haleon plc (HLN) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Drug Manufacturers - Specialty & Generic industria. La empresa tiene su sede en Weybridge, United Kingdom. El CEO actual es Brian James McNamara.
HLN tiene fecha de IPO 2022-07-25, 24,561 empleados a tiempo completo, cotiza en el NYSE, una capitalización de mercado de $43.05B.
Haleon plc is a consumer healthcare company headquartered in Brentford, United Kingdom, engaged in the research, development, manufacture, and distribution of over-the-counter health and wellness products across North America, Europe, the Middle East, Africa, Latin America, and Asia Pacific. The company's extensive portfolio spans therapeutic oral health, pain relief, respiratory health, digestive health, vitamins, minerals, and supplements, featuring globally recognized brands including Panadol, Voltaren, Advil, Sensodyne, Theraflu, Otrivin, Polident, parodontax, and Centrum. Since its incorporation in 2021 and rebranding to Haleon plc in February 2022, the company has positioned itself as a leading player in the consumer healthcare sector.
